Hota KB, Hota SK, Chaurasia OP, Singh SB
Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly prescribed for type 2 diabetes and weight management across the UK
There was more hypoglycemia and weight gain (+1.1 kg) in the glipizide group, whereas the sitagliptin group had weight loss (-1.5 kg)
Furthermore, the Inuit often presented with several nutritional deficiencies
But some states, such as Michigan, have restricted eligibility for these medications to morbidly obesity patients rather than those who are overweight or obese
52 Older research shows that intravenous (IV) glutathione significantly boosted both cysteine, an amino acid needed to make glutathione, and total glutathione in the blood